Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preservative-free brimonidine + timolol versus Combigan in open-angle glaucoma or ocular hypertension
2015-000160-34Phase 3Completed
- Sponsor
- OmniVision
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in open-angle glaucoma (OAG) and ocular hypertension comparing Preservative-free brimonidine + timolol with Combigan (2 arms). Started May 2015; status: completed.
02
Drugs
brimonidinetimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2015-000160-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000160-34.